Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 18, 2003
Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects
James H Schluger, Gavin Bart, Mark Green, et al.
BMC Public Health
|
April 2, 2020
HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study
Caroline King, Le Minh Giang, Gavin Bart, et al.
Drug and Alcohol Dependence
|
July 12, 2020
Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018
Riley D Shearer, Benjamin A Howell, Gavin Bart, et al.
Journal of Addiction Medicine
|
August 12, 2021
Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 - 2020
Amber R Lindsay, Riley D Shearer, Gavin Bart, et al.
Drug and Alcohol Dependence
|
November 19, 2022
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability
Gavin Bart, Mutaz Jaber, Le Minh Giang, et al.
The Journal of Mental Health Policy and Economics
|
December 19, 2023
Financial Sustainability of Novel Delivery Models in Behavioral Health Treatment
Dominic Hodgkin, Constance M Horgan, Stephanie Jordan Brown, et al.
Pharmacological Reviews
|
March 1, 2005
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments
Mary Jeanne Kreek, Gavin Bart, Charles Lilly, et al.
Drug and Alcohol Dependence
|
September 5, 2021
Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study
Gavin Bart, Le Minh Giang, Hoang Yen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 6, 2003
Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects
Gavin Bart, Lisa Borg, James H Schluger, et al.
Neuropharmacology
|
October 7, 2004
Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA
Mary Jeanne Kreek, Stefan D Schlussman, Gavin Bart, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 18, 2003
Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects
James H Schluger, Gavin Bart, Mark Green, et al.
BMC Public Health
|
April 2, 2020
HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study
Caroline King, Le Minh Giang, Gavin Bart, et al.
Drug and Alcohol Dependence
|
July 12, 2020
Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018
Riley D Shearer, Benjamin A Howell, Gavin Bart, et al.
Journal of Addiction Medicine
|
August 12, 2021
Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 - 2020
Amber R Lindsay, Riley D Shearer, Gavin Bart, et al.
Drug and Alcohol Dependence
|
November 19, 2022
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability
Gavin Bart, Mutaz Jaber, Le Minh Giang, et al.
The Journal of Mental Health Policy and Economics
|
December 19, 2023
Financial Sustainability of Novel Delivery Models in Behavioral Health Treatment
Dominic Hodgkin, Constance M Horgan, Stephanie Jordan Brown, et al.
Pharmacological Reviews
|
March 1, 2005
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments
Mary Jeanne Kreek, Gavin Bart, Charles Lilly, et al.
Drug and Alcohol Dependence
|
September 5, 2021
Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study
Gavin Bart, Le Minh Giang, Hoang Yen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 6, 2003
Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects
Gavin Bart, Lisa Borg, James H Schluger, et al.
Neuropharmacology
|
October 7, 2004
Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA
Mary Jeanne Kreek, Stefan D Schlussman, Gavin Bart, et al.
Page
of 9